243 related articles for article (PubMed ID: 28550465)
1. Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.
Yoon HJ; Ahn KJ; Lee S; Jang JH; Choi HS; Jung SL; Kim BS; Jeun SS; Hong YK
Neuroradiology; 2017 Jul; 59(7):665-675. PubMed ID: 28550465
[TBL] [Abstract][Full Text] [Related]
2. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A
Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139
[TBL] [Abstract][Full Text] [Related]
3. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.
Shinozaki N; Uchino Y; Yoshikawa K; Matsutani T; Hasegawa A; Saeki N; Iwadate Y
J Neurosurg; 2011 Jun; 114(6):1640-7. PubMed ID: 21214332
[TBL] [Abstract][Full Text] [Related]
4. Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors.
Saito T; Yamasaki F; Kajiwara Y; Abe N; Akiyama Y; Kakuda T; Takeshima Y; Sugiyama K; Okada Y; Kurisu K
Eur J Radiol; 2012 Aug; 81(8):1863-9. PubMed ID: 21543173
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
[TBL] [Abstract][Full Text] [Related]
7. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
9. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
10. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion.
Bauer AH; Erly W; Moser FG; Maya M; Nael K
Neuroradiology; 2015 Jul; 57(7):697-703. PubMed ID: 25845813
[TBL] [Abstract][Full Text] [Related]
12. MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.
Zhang S; Chiang GC; Magge RS; Fine HA; Ramakrishna R; Chang EW; Pulisetty T; Wang Y; Zhu W; Kovanlikaya I
Magn Reson Imaging; 2019 Apr; 57():254-258. PubMed ID: 30465868
[TBL] [Abstract][Full Text] [Related]
13. [Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult].
Lamy-Lhullier C; Dubois F; Blond S; Lecouffe P; Steinling M
Neurochirurgie; 1999 May; 45(2):110-7. PubMed ID: 10448650
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
You SH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST; Choi HJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Radiology; 2018 Mar; 286(3):981-991. PubMed ID: 29244617
[TBL] [Abstract][Full Text] [Related]
16. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
[TBL] [Abstract][Full Text] [Related]
17. Grading of oligodendroglial tumors of the brain with apparent diffusion coefficient, magnetic resonance spectroscopy, and dynamic susceptibility contrast imaging.
Naveed MA; Goyal P; Malhotra A; Liu X; Gupta S; Mangla M; Mangla R
Neuroradiol J; 2018 Aug; 31(4):379-385. PubMed ID: 29469659
[TBL] [Abstract][Full Text] [Related]
18. Low-grade and anaplastic oligodendrogliomas: differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging.
Jia Z; Geng D; Liu Y; Chen X; Zhang J
J Clin Neurosci; 2013 Aug; 20(8):1110-3. PubMed ID: 23673143
[TBL] [Abstract][Full Text] [Related]
19. SWI by 7T MR Imaging for the Microscopic Imaging Diagnosis of Astrocytic and Oligodendroglial Tumors.
Natsumeda M; Matsuzawa H; Watanabe M; Motohashi K; Gabdulkhaev R; Tsukamoto Y; Kanemaru Y; Watanabe J; Ogura R; Okada M; Kurabe S; Okamoto K; Kakita A; Igarashi H; Fujii Y
AJNR Am J Neuroradiol; 2022 Nov; 43(11):1575-1581. PubMed ID: 36229164
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
